Hypermarcas (OTCMKTS:HYPMY) Short Interest Down 99.9% in December

Hypermarcas (OTCMKTS:HYPMY) was the target of a large decline in short interest in December. As of December 15th, there was short interest totaling 16 shares, a decline of 99.9% from the November 30th total of 11,176 shares. Currently, 0.0% of the shares of the stock are sold short. Based on an average daily trading volume, of 13,330 shares, the days-to-cover ratio is currently 0.0 days. Based on an average daily trading volume, of 13,330 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.0% of the shares of the stock are sold short.

Hypermarcas Price Performance

Hypermarcas stock traded down $0.15 during mid-day trading on Friday, hitting $4.26. 420 shares of the company were exchanged, compared to its average volume of 51,243. The company has a market capitalization of $2.70 billion, a PE ratio of 18.52 and a beta of 0.73. The business has a fifty day moving average of $4.54 and a 200 day moving average of $4.51. Hypermarcas has a 1-year low of $2.86 and a 1-year high of $5.18. The company has a quick ratio of 0.84, a current ratio of 1.27 and a debt-to-equity ratio of 0.61.

Hypermarcas (OTCMKTS:HYPMY) last issued its earnings results on Wednesday, November 12th. The company reported $0.13 EPS for the quarter. The company had revenue of $408.83 million for the quarter. Hypermarcas had a net margin of 12.03% and a return on equity of 6.89%.

Hypermarcas Company Profile

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.